Definium Therapeutics News and Activities

Presence

Definium Therapeutics is a biotechnology company that develops targeted medicines and drug discovery services. Its products and research programs support pharmaceutical partners, healthcare researchers, and patients with difficult diseases.

Definium Therapeutics products and services overview:

  • Targeted therapies
  • Drug discovery
  • Research services
  • Therapeutic platforms

Revenue: ~$0 million

Employees: 15

Headquarters: Toronto, Canada


Definium Therapeutics is one of the...

Definium Therapeutics is a company listed under the stock ticker DFTX (US).

Acquisition, funding and merger involving Definium Therapeutics.

Executives

View the org chart displaying its 20 main executives

Most searched biographies at Definium Therapeutics
Popular executive movements at Definium Therapeutics
  • Roger Adsett has joined the company as Director  (posted on January 29 2026).

Create your alert
to follow the executive moves at Definium Therapeutics.

Biotechnology

Definium Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Definium Therapeutics
Social media about Definium Therapeutics

Get in Touch

Call Definium Therapeutics at +1 514...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board